Kidney Health Initiative: partnership to speed better kidney treatments
Official title: Kidney Health Initiative is a public-private partnership between the American Society of Nephrology, US Food and Drug Administration and the kidney community.
Funded at American Society of Nephrology, INC. · NIH-11194514 · Data updated 2026-11-12
A national partnership that brings patients, doctors, industry, and the FDA together to help create better medicines, devices, and patient-centered trial measures for people with kidney disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | American Society of Nephrology, INC. NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | September 1, 2014 |
| Project end | August 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $300,000 |
| NIH project number | 5R18FD005283-12 |
| Project ID | NIH-11194514 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with any form of kidney disease who want to share their experience, join advisory panels, or take part in pilot projects or patient-centered measurement studies.
✕Less likely to help
Patients without kidney disease or those not participating in advisory or pilot activities are unlikely to see direct benefits from this initiative.
What this research studies
As a person with kidney disease, you can benefit because this partnership brings together doctors, the FDA, industry, and patients to tackle barriers to new treatments. They develop and pilot clinical trial endpoints, create roadmaps for product development, and build tools to make patient priorities part of research. KHI organizes working groups, convenes experts and patient advisors, and turns consensus recommendations into practical guidance for companies and regulators. Their work aims to make future trials and devices more relevant to patients and faster to reach clinical use.
Why it matters
Potential benefit: Could help speed safer, more patient-focused kidney drugs, devices, and tests to people living with kidney disease by improving trial design and regulatory guidance.
How similar studies have gone: Other public–private partnerships and consensus initiatives in medicine have successfully produced guidance and trial tools that improved development pathways, so this approach has precedent.
Where this research is happening
-
American Society of Nephrology, INC.
Washington, United States Active
Researchers
- Principal investigator: Ibrahim, Tod Ramses — American Society of Nephrology, INC.
- Study coordinator: Ibrahim, Tod Ramses
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.